Brief: NARB Recommends Niagen Modify/Discontinue Certain Tru Niagen Nad+ Dietary Supplement Claims
May 21 (Reuters) - National Advertising Review Board: NATIONAL ADVERTISING REVIEW BOARD RECOMMENDS NIAGEN MODIFY OR DISCONTINUE CERTAIN TRU NIAGEN NAD+ DIETARY SUPPLEMENT CLAIMS Source text: ID:nGNE3DZfpj Further company coverage: NAGE.O ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Niagen Bioscience
See all newsAs weight-loss drug users turn to dietary supplements, doctors, regulators raise flags
Niagen Bioscience Inc reports results for the quarter ended June 30 - Earnings Summary
Niagen Bioscience Q2 net sales fall, missing estimates
Niagen Bioscience Inc expected to post earnings of 2 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-SpaceX, Sandisk, Salesforce